MPLT · MapLight Therapeutics, Inc. · Executive Compensation
$9.28
-0.55 (-5.55%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$485.11M
Shares
46.38M
Volume · Oct 5
262.13K
Avg daily vol (3M)
852.35K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Christopher A. Kroeger | President and Chief Executive Officer | $25,624,254 |
| Erin Pennock Foff | M.D., Ph.D. Chief Medical Officer | $6,254,000 |
| Vishwas Setia | Chief Financial Officer | $6,202,564 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Christopher A. Kroeger | President and Chief Executive Officer | $8,789,142 |
| Vishwas Setia | Chief Financial Officer | $3,068,975 |
| Erin Pennock Foff | M.D., Ph.D. Chief Medical Officer | $2,752,751 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jonathan Gillis | interim Chief Financial Officer | Appointed | 2026-06-18 |
| Jonathan Gillis | interim principal financial officer | Appointed | 2026-06-18 |
| Vishwas Setia | Chief Financial Officer | Terminated | 2026-06-18 |